Livzon Pharma Cancels Millions of Share Options
Company Announcements

Livzon Pharma Cancels Millions of Share Options

Livzon Pharmaceutical Group (HK:1513) has released an update.

Livzon Pharmaceutical Group Inc. has announced the complete cancellation of a significant number of share options under its 2022 Share Options Incentive Scheme. A total of 6,283,750 share options have been cancelled following verification by the Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. This move aligns with the company’s previously disclosed intentions and has been fully executed as of May 27, 2024.

For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskLivzon Pharmaceutical Reports Mixed Q3 2024 Financial Results
TipRanks HongKong Auto-Generated NewsdeskLivzon Pharmaceutical Proposes New Non-Executive Director
TipRanks HongKong Auto-Generated NewsdeskLivzon Pharmaceutical Group Plans Key Meeting for 2024
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App